Beximco Pharmaceuticals
제약 제제, 일반 의약품 및 건강 관리 제품.
Beximco Pharmaceuticals는 다카 사업장에서 의약품 제제, 제네릭 의약품 및 건강 관리 제품을 제조합니다. 이 회사는 나열된 주요 시장 전반에 걸쳐 약국 채널, 병원 구매자, 의료 유통업체 또는 수출 고객에게 제품을 공급합니다.
- Type
- Manufacturer
- Location
- Dhaka, Bangladesh
- Founded
- 1976
- Website
- beximco-pharma.com
- Categories
- 의료 및 건강 관리 용품, 보충제 및 웰니스
- Markets
- 방글라데시, 미국, 영국, 오스트레일리아
Verified facts
- lei-active (green), checked 2026-08-05 GLEIF
- web-presence-since (green), checked 2026-08-05 Internet Archive (Wayback)
- debarment-clear (green), checked 2026-08-05 OpenSanctions
- sanctions-clear (green), checked 2026-08-05 OpenSanctions
- domain-registered (green), checked 2026-08-05 Domain registry record
- corporate-mail-on-domain (green), checked 2026-08-05 Mail server of the company domain
Claimed certifications
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)